当前位置： SCI文献检索 > ONCOGENE期刊下所有文献 > Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.

Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.

Abstract：

:Imatinib-acquired resistance related to the presence of secondary point mutations has become a frequent event in gastrointestinal stromal tumors. Here, transient transfection experiments with plasmids carrying two different KIT-acquired point mutations were performed along with immunoprecipitation of total protein extracts, derived from imatinib-treated and untreated cells. The molecular mechanics/Poisson Boltzmann surface area computational techniques were applied to study the interactions of the wild-type and mutated receptors with imatinib at the molecular level. Biochemical analyses showed KIT phosphorylation in cells transfected with vectors carrying the specific mutant genes. Imatinib treatment demonstrated that T670I was insensitive to the drug at all the applied concentrations, whereas V654A was inhibited by 6 microM of imatinib. The modeling of the mutated receptors revealed that both substitutions affect imatinib-binding site, but to a different extent: T670I substantially modifies the binding pocket, whereas V654A induces only relatively confined structural changes. We demonstrated that T670I and V654A cause indeed imatinib-acquired resistance and that the former is more resistant to imatinib than the latter. The application of molecular simulations allowed us to quantify the interactions between the mutated receptors and imatinib, and to propose a molecular rationale for this type of drug resistance.

journal_name

Oncogene

journal_title

Oncogene

authors

Tamborini E,Pricl S,Negri T,Lagonigro MS,Miselli F,Greco A,Gronchi A,Casali PG,Ferrone M,Fermeglia M,Carbone A,Pierotti MA,Pilotti S

doi

10.1038/sj.onc.1209639

subject

Has Abstract

pub_date

2006-10-05 00:00:00

pages

6140-6

issue

45

eissn

0950-9232

issn

1476-5594

pii

1209639

journal_volume

25

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway.

    abstract：:Glioma stem cells (GSCs) decrease T cells cognition and evade systemic immunosurveillance via downregulations or defects of major histocompatibility complex class I (MHC-I) molecule and antigen-processing machinery (APM) components. Improvement of tumor surface antigens of GSCs may be effective strategy to trigger an ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-019-1045-6

    authors： Yang W,Li Y,Gao R,Xiu Z,Sun T

    更新日期：2020-01-01 00:00:00

  • Identification of genomic DNA sequences bound by mutant p53 protein (Gly245-->Ser) in vivo.

    abstract：:Mutant p53 proteins were shown to exert complex DNA-interactions in vitro, like binding to MAR-DNA, but so far it is unknown whether such interactions also occur in vivo. Therefore we analysed the binding of mutant (mut) p53 (Gly245-->Ser) in Onda 11 glioma cells to cellular DNA in vivo, using p53-specific chromatin i...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1203745

    authors： Koga H,Deppert W

    更新日期：2000-08-24 00:00:00

  • ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block.

    abstract：:Using a temperature-sensitive mutant of the p210 BCR-ABL gene, transfected into a growth factor-dependent cell line (BaF3), we show that transient BCR-ABL kinase expression increases single cell and clonogenic resistance to apoptosis arising from genotoxic damage induced by ionizing radiation and VP-16/etoposide. This...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Nishii K,Kabarowski JH,Gibbons DL,Griffiths SD,Titley I,Wiedemann LM,Greaves MF

    更新日期：1996-11-21 00:00:00

  • Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways.

    abstract：:Many of the signaling responses induced by transforming growth factor-beta (TGF-beta) are mediated by Smad proteins, but there is evidence that it can also signal independently of Smads. Here, we provide evidence that multiple signal pathways induced by TGF-beta1-including Src family tyrosine kinases (SFKs), generatio...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210649

    authors： Joo CK,Kim HS,Park JY,Seomun Y,Son MJ,Kim JT

    更新日期：2008-01-24 00:00:00

  • β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.

    abstract：:Nuclear activated β-catenin plays a causative role in colorectal cancers (CRC) but remains an elusive therapeutic target. Using human CRC cells harboring different Wnt/β-catenin pathway mutations in APC/KRAS or β-catenin/KRAS genes, and both genetic and pharmacological knockdown approaches, we show that oncogenic β-ca...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-018-0170-y

    authors： Saponaro C,Sergio S,Coluccia A,De Luca M,La Regina G,Mologni L,Famiglini V,Naccarato V,Bonetti D,Gautier C,Gianni S,Vergara D,Salzet M,Fournier I,Bucci C,Silvestri R,Passerini CG,Maffia M,Coluccia AML

    更新日期：2018-06-01 00:00:00

  • Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1.

    abstract：:Our previous work with primary bovine fibroblasts demonstrated that quercetin, a potent mutagen found in high levels in bracken fern (Pteridium aquilinum), arrested cells in G1 and G2/M, in correlation with p53 activation. The expression of bovine papillomavirus type 4 (BPV-4) E7 overcame this arrest and lead to the d...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206848

    authors： Beniston RG,Campo MS

    更新日期：2003-08-21 00:00:00

  • p53 isoform profiling in glioblastoma and injured brain.

    abstract：:The tumor suppressor p53 has been found to be the most commonly mutated gene in human cancers; however, the frequency of p53 mutations varies from 10 to 70% across different cancer types. This variability can partly be explained by inactivating mechanisms aside from direct genomic polymorphisms. The p53 gene encodes 1...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.322

    authors： Takahashi R,Giannini C,Sarkaria JN,Schroeder M,Rogers J,Mastroeni D,Scrable H

    更新日期：2013-06-27 00:00:00

  • Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.

    abstract：:The clonality of lymphomas that originate in myc/pim-1 bitransgenic mice due to synergistic action of both oncogenes indicates the requirement of additional events for progression to full malignancy. To isolate genes that cooperate with both myc and pim-1, we have used provirus tagging with E mu L-myc/pim-1 double tra...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Zörnig M,Schmidt T,Karsunky H,Grzeschiczek A,Möröy T

    更新日期：1996-04-18 00:00:00

  • MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.

    abstract：:In the childhood cancer neuroblastoma (NB), the level of expression of the multidrug resistance-associated protein (MRP1) gene is strongly correlated with expression of the MYCN oncogene in primary NB tumors, suggesting that MRP1 may be a target for MYCN-mediated gene regulation. In this study, we show that MYCN induc...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1207151

    authors： Manohar CF,Bray JA,Salwen HR,Madafiglio J,Cheng A,Flemming C,Marshall GM,Norris MD,Haber M,Cohn SL

    更新日期：2004-01-22 00:00:00

  • Genome-wide mechanisms of Smad binding.

    abstract：:A dual role of transforming growth factor β (TGF-β), to both suppress and promote tumor progression and metastasis, has been well established, but its molecular basis has remained elusive. In this review, we focus on Smad proteins, which are central mediators of the signal transduction of TGF-β family members. We desc...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/onc.2012.191

    authors： Morikawa M,Koinuma D,Miyazono K,Heldin CH

    更新日期：2013-03-28 00:00:00

  • Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.

    abstract：:Activation of the Met tyrosine kinase growth factor receptor by its ligand HGF/SF has been shown to increase in vitro invasiveness in epithelial cell lines. To study the effect of Met-HGF/SF signaling in breast cancer cells, we transfected met, hgf/sf and dominant negative (DN) forms of met into the poorly differentia...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1203557

    authors： Firon M,Shaharabany M,Altstock RT,Horev J,Abramovici A,Resau JH,Vande Woude GF,Tsarfaty I

    更新日期：2000-05-11 00:00:00

  • Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.

    abstract：:Retinoids have been shown to inhibit the growth of a number of human tumor cells, including several ovarian adenocarcinoma cell lines. All-trans retinoic acid (RA) is an effective growth suppressor of CA-OV3 cells but not SK-OV3 cells. Since the effects of RA are known to be mediated via the nuclear receptors (RARs an...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202208

    authors： Wu S,Zhang D,Zhang ZP,Soprano DR,Soprano KJ

    更新日期：1998-12-03 00:00:00

  • Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.

    abstract：:Initiation of DNA replication requires the function of MCM gene products, which participate in ensuring that DNA replication occurs only once in the cell cycle. Expression of all mammalian genes of the MCM family is induced by growth stimulation, unlike yeast, and the mRNA levels peak at G1/S boundary. In this study, ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202544

    authors： Ohtani K,Iwanaga R,Nakamura M,Ikeda M,Yabuta N,Tsuruga H,Nojima H

    更新日期：1999-04-08 00:00:00

  • Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

    abstract：:Human papillomaviruses (HPVs) are involved in the pathogenesis of cancer of the cervix (CaCx). MicroRNA (miRNA) expression analysis using Ambion (Austin, TX, USA) arrays showed that three miRNAs were overexpressed and 24 underexpressed in cervical cell lines containing integrated HPV-16 DNA compared to the normal cerv...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210919

    authors： Martinez I,Gardiner AS,Board KF,Monzon FA,Edwards RP,Khan SA

    更新日期：2008-04-17 00:00:00

  • High frequency of p16INK4A gene alterations in hepatocellular carcinoma.

    abstract：:The tumor suppressor gene p16 (CDKN2/MTS-1/INK4A) is an important component of the cell cycle and inactivation of the gene has been found in a variety of human cancers. In order to investigate the role of p16 gene in the tumorigenesis of hepatocellular carcinoma (HCC), 48 cases of HCC were analysed for p16 alterations...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202359

    authors： Liew CT,Li HM,Lo KW,Leow CK,Chan JY,Hin LY,Lau WY,Lai PB,Lim BK,Huang J,Leung WT,Wu S,Lee JC

    更新日期：1999-01-21 00:00:00

  • MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism.

    abstract：:The Mucin 1 (MUC1) protein is overexpressed in various cancers and mediates chemotherapy resistance. However, the mechanism is not fully understood. Given that most chemotherapeutic drugs disrupt ER homeostasis as part of their toxicity, and MUC1 expression is regulated by proteins involved in ER homeostasis, we inves...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-020-1225-4

    authors： Olou AA,King RJ,Yu F,Singh PK

    更新日期：2020-04-01 00:00:00

  • aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia.

    abstract：:Atypical protein kinase C (aPKC) and Lethal giant larvae (Lgl) regulate apical-basal polarity in Drosophila and mammalian epithelia. At the apical domain, aPKC phosphorylates and displaces Lgl that, in turn, maintains aPKC inactive at the basolateral region. The mutual exclusion of these two proteins seems to be cruci...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210389

    authors： Grifoni D,Garoia F,Bellosta P,Parisi F,De Biase D,Collina G,Strand D,Cavicchi S,Pession A

    更新日期：2007-08-30 00:00:00

  • High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.

    abstract：:The few imprinted genes characterized so far include the insulin-like growth factor-2 gene (IGF2) coding for a foetal growth factor and the H19 gene whose normal function is unknown but which is likely to act as an RNA with an antitumour effect. IGF2 is expressed by the paternal allele and H19 by the maternal allele. ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Douc-Rasy S,Barrois M,Fogel S,Ahomadegbe JC,Stéhelin D,Coll J,Riou G

    更新日期：1996-01-18 00:00:00

  • The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.

    abstract：:ASPP1 and ASPP2 are both proteins that interact with p53 and enhance its ability to induce apoptosis by selectively elevating the expression of proapoptotic p53-responsive genes. iASPP(RAI) is a third member of the family that is the most conserved inhibitor of p53-mediated apoptosis. Here, we have described iASPP, a ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1208088

    authors： Slee EA,Gillotin S,Bergamaschi D,Royer C,Llanos S,Ali S,Jin B,Trigiante G,Lu X

    更新日期：2004-12-02 00:00:00

  • Identifying targets for the restoration and reactivation of BRM.

    abstract：:Brahma (BRM) is a novel anticancer gene, which is frequently inactivated in a variety of tumor types. Unlike many anticancer genes, BRM is not mutated, but rather epigenetically silenced. In addition, histone deacetylase complex (HDAC) inhibitors are known to reverse BRM silencing, but they also inactivate it via acet...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.613

    authors： Kahali B,Gramling SJ,Marquez SB,Thompson K,Lu L,Reisman D

    更新日期：2014-01-30 00:00:00

  • Enhancement of c-fos expression is associated with activated macrophages.

    abstract：:Unique hybrids (HINS and CANS lines) between macrophages and a myeloma cell line, NS1 initially expressed myeloma functions but later expressed active macrophage functions together with constitutive expression of c-fos gene. Enhancement of c-fos transcription was also observed in activated mouse peritoneal macrophages...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Higuchi Y,Setoguchi M,Yoshida S,Akizuki S,Yamamoto S

    更新日期：1988-05-01 00:00:00

  • Influence of Ras and retinoic acid on nerve growth factor induction of transin gene expression in PC12 cells.

    abstract：:Nerve growth factor (NGF)- and ras-induced neuronal differentiation of PC12 cells is accompanied by expression of transin, a secreted metalloproteinase. Retinoic acid (RA) is known to exert important effects on neural cell proliferation and differentiation. In this study we have analysed different PC12 sublines which ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1200997

    authors： Cosgaya JM,Recio JA,Aranda A

    更新日期：1997-04-10 00:00:00

  • Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.

    abstract：:Tuberin is the protein product of the tuberous sclerosis-2 (TSC2) gene, which is associated with tuberous sclerosis (TSC), a human genetic syndrome characterized by the development of tumors in a variety of tissues. We have previously shown that tuberin is a widely expressed 180 kDa protein which exhibits specific GTP...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Wienecke R,Maize JC Jr,Shoarinejad F,Vass WC,Reed J,Bonifacino JS,Resau JH,de Gunzburg J,Yeung RS,DeClue JE

    更新日期：1996-09-05 00:00:00

  • Chimeric c-Jun containing an heterologous homodimerization domain transforms primary chick embryo fibroblasts.

    abstract：:To investigate a possible role for c-Jun homodimers in c-Jun-mediated transformation, we designed two chimeric c-Jun derivatives, called c-Juneb1 and c-Jungcn4. In these chimeric derivatives the natural dimerization domain of c-Jun was replaced by the heterologous homodimerization domain of the Epstein-Barr virus EB1 ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Castellazzi M,Loiseau L,Piu F,Sergeant A

    更新日期：1993-05-01 00:00:00

  • ROS release by PPARβ/δ-null fibroblasts reduces tumor load through epithelial antioxidant response.

    abstract：:Tumor stroma has an active role in the initiation, growth, and propagation of many tumor types by secreting growth factors and modulating redox status of the microenvironment. Although PPARβ/δ in fibroblasts was shown to modulate oxidative stress in the wound microenvironment, there has been no evidence of a similar e...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-017-0109-8

    authors： Tan EHP,Sng MK,How ISB,Chan JSK,Chen J,Tan CK,Wahli W,Tan NS

    更新日期：2018-04-01 00:00:00

  • High levels of the c-myc protein in cell lines of Bloom's syndrome origin.

    abstract：:Lymphoblastoid cell lines derived from cancer prone Bloom's Syndrome patients differ from cell lines representative of several other disorders by exhibiting a constitutive elevation in the level of the c-myc protein. This may be a contributing factor in the strong predisposition to malignancy observed in Bloom's syndr...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Sullivan NF,Willis AE,Moore JP,Lindahl T

    更新日期：1989-12-01 00:00:00

  • The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367.

    abstract：:The MYCN gene has been implicated in certain neuronal tumours, such as neuroblastomas and retinoblastomas. These tumours express high levels of mRNA and protein of MYCN as a result of amplification. MYCN encodes a short-lived nuclear phosphoprotein whose function has not yet been elucidated. This study was undertaken ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Hamann U,Wenzel A,Frank R,Schwab M

    更新日期：1991-10-01 00:00:00

  • G-proteins in growth and apoptosis: lessons from the heart.

    abstract：:The acute contractile function of the heart is controlled by the effects of released nonepinephrine (NE) on cardiac adrenergic receptors. NE can also act in a more chronic fashion to induce cardiomyocyte growth, characterized by cell enlargement (hypertrophy), increased protein synthesis, alterations in gene expressio...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1204275

    authors： Adams JW,Brown JH

    更新日期：2001-03-26 00:00:00

  • The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.

    abstract：:Disseminated breast cancer cells employ adaptive molecular responses following cytotoxic therapeutic insult which promotes their survival and subsequent outgrowth. Here we demonstrate that expression of the pro-metastatic lncRNA BORG (BMP/OP-Responsive Gene) is greatly induced within triple-negative breast cancer (TNB...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-018-0586-4

    authors： Gooding AJ,Zhang B,Gunawardane L,Beard A,Valadkhan S,Schiemann WP

    更新日期：2019-03-01 00:00:00

  • FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

    abstract：:In this study, we investigated the regulation of FOXM1 expression by estrogen receptor alpha (ERalpha) and its role in hormonal therapy and endocrine resistance. FOXM1 protein and mRNA expression was regulated by ER-ligands, including estrogen, tamoxifen (OHT) and fulvestrant (ICI182780; ICI) in breast carcinoma cell ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2010.47

    authors： Millour J,Constantinidou D,Stavropoulou AV,Wilson MS,Myatt SS,Kwok JM,Sivanandan K,Coombes RC,Medema RH,Hartman J,Lykkesfeldt AE,Lam EW

    更新日期：2010-05-20 00:00:00